lenalidomide has been researched along with HIV Coinfection in 15 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (6.67) | 29.6817 |
2010's | 7 (46.67) | 24.3611 |
2020's | 7 (46.67) | 2.80 |
Authors | Studies |
---|---|
Aboulafia, D; Ambinder, RF; Baiocchi, R; Bui, JD; Chiao, EY; Dittmer, DP; Han, S; Martínez-Maza, O; Maurer, T; Mitsuyasu, R; Moore, P; Reid, EG; Shimabukuro, K; Wachsman, W | 1 |
Henry, DH; Maki, RG | 1 |
Kodad, SG; Sabry, W; Wu, Y | 1 |
Guo, Y; Hang, Y; Hui, J; Liu, X; Peng, X; Tao, R; Wan, Z; Zhu, B; Zhu, X | 1 |
Guo, Y; Huang, Y; Hui, J; Liu, X; Peng, X; Tao, R; Wan, Z; Zhu, B; Zhu, X | 1 |
Lin, X; Wang, J; Wang, X; Wen, Y; Yan, X; Zhou, Y | 1 |
Chen, J; Liu, L; Qi, T; Song, W; Sun, J; Tang, Y; Wang, Z; Xu, S; Yang, J; Zhang, R | 1 |
Kobayashi, Z | 1 |
Sato, S | 1 |
Assoumou, L; Boué, F; Cardon, F; Chennebault, JM; Costagliola, D; Curjol, A; Desnoyer, A; Gibowski, S; Lebbe, C; Marcelin, AG; Peytavin, G; Poizot-Martin, I; Pourcher, V; Salmon, D | 1 |
Blum, S; Cavassini, M; Fayet, A; Jotterand, M; Lambert, JF; Schapira, M | 1 |
Alba, L; Antinori, A; Bibas, M; Del Nonno, F; Grisetti, S; Picchi, G | 1 |
Aerts, JL; Allard, SD; De Keersmaecker, B; Lacor, P; Schots, R; Thielemans, K | 1 |
Deeks, SG; Ferrucci, L; Goetzl, EJ; Greig, N; Hesdorffer, CS; Kane, L; Lim, H; Schwartz, JB | 1 |
Hanekom, WA; Haslett, PA; Kaplan, G; Muller, G | 1 |
1 trial(s) available for lenalidomide and HIV Coinfection
Article | Year |
---|---|
Phase II Trial of Lenalidomide in HIV-Infected Patients with Previously Treated Kaposi's Sarcoma: Results of the ANRS 154 Lenakap Trial.
Topics: Adolescent; Adult; Aged; Angiogenesis Inhibitors; Drug-Related Side Effects and Adverse Reactions; Female; HIV Infections; Humans; Lenalidomide; Male; Middle Aged; Sarcoma, Kaposi; Thalidomide; Treatment Outcome; Young Adult | 2017 |
14 other study(ies) available for lenalidomide and HIV Coinfection
Article | Year |
---|---|
AMC-070: Lenalidomide Is Safe and Effective in HIV-Associated Kaposi Sarcoma.
Topics: Cytokines; Herpesvirus 8, Human; HIV Infections; Humans; Lenalidomide; Sarcoma, Kaposi | 2022 |
Lenalidomide and the Expanding Toolkit to Manage Kaposi Sarcoma.
Topics: HIV Infections; Humans; Lenalidomide; Sarcoma, Kaposi | 2022 |
Bortezomib, Lenalidomide and Dexamethasone Combination Induced Complete Remission in Relapsed/Refractory Plasmablastic Lymphoma: Case Report of a Potential Novel Treatment Approach.
Topics: Bortezomib; Dexamethasone; HIV Infections; Humans; Lenalidomide; Neoplasm Recurrence, Local; Plasmablastic Lymphoma | 2022 |
Lenalidomide potentially reduced the level of cell- associated HIV RNA and improved persistent inflammation in patients with HIV-associated cryptococcal meningitis a pilot study.
Topics: Cytokines; HIV Infections; HIV-1; Humans; Inflammation; Interleukin-6; Lenalidomide; Leukocytes, Mononuclear; Meningitis, Cryptococcal; Pilot Projects; RNA, Viral; Tumor Necrosis Factor-alpha | 2022 |
Efficacy and safety of lenalidomide in HIV-associated cryptococcal meningitis patients with persistent intracranial inflammation: an open-label, single-arm, prospective interventional study.
Topics: Albumins; HIV; HIV Infections; Humans; Inflammation; Lenalidomide; Meningitis, Cryptococcal; Prospective Studies | 2023 |
Sustained response following BTK inhibitors based treatment in HIV-related primary central nervous system lymphoma: case report.
Topics: Agammaglobulinaemia Tyrosine Kinase; Central Nervous System; HIV; HIV Infections; Humans; Lenalidomide; Lymphoma | 2023 |
Zanubrutinib, lenalidomide, and rituximab (ZR2 regimen) for HIV-associated diffuse large B-cell lymphoma: a real-world analysis from China.
Topics: China; HIV Infections; Humans; Lenalidomide; Lymphoma, Large B-Cell, Diffuse; Rituximab | 2023 |
Did This Cryptococcosis Patient Have HIV Coinfection?
Topics: Antibodies, Monoclonal; Cryptococcosis; Dexamethasone; HIV Infections; Humans; Lenalidomide; Multiple Myeloma | 2019 |
The Author's Reply to "Did This Cryptococcosis Patient Have HIV Coinfection?"
Topics: Antibodies, Monoclonal; Cryptococcosis; Dexamethasone; HIV Infections; Humans; Lenalidomide; Multiple Myeloma | 2019 |
Treatment of 5q-syndrome with lenalidomide in an HIV-positive patient under cART.
Topics: Anti-HIV Agents; Chromosome Deletion; Chromosomes, Human, Pair 5; Drug Therapy, Combination; HIV Infections; Humans; Lenalidomide; Lymphocyte Count; Lymphocytes; Male; Middle Aged; Thalidomide | 2010 |
Patient with HIV-associated plasmablastic lymphoma responding to bortezomib alone and in combination with dexamethasone, gemcitabine, oxaliplatin, cytarabine, and pegfilgrastim chemotherapy and lenalidomide alone.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Antiretroviral Therapy, Highly Active; Boronic Acids; Bortezomib; Cytarabine; Deoxycytidine; Dexamethasone; Filgrastim; Gemcitabine; Granulocyte Colony-Stimulating Factor; HIV Infections; Humans; Lenalidomide; Lymphoma, Large-Cell, Immunoblastic; Male; Neoplasm Staging; Organoplatinum Compounds; Oxaliplatin; Polyethylene Glycols; Pyrazines; Recombinant Proteins; Thalidomide; Young Adult | 2010 |
Expansion of polyfunctional HIV-specific T cells upon stimulation with mRNA electroporated dendritic cells in the presence of immunomodulatory drugs.
Topics: CD8-Positive T-Lymphocytes; Cells, Cultured; Dendritic Cells; Electroporation; gag Gene Products, Human Immunodeficiency Virus; HIV Infections; HIV-1; Humans; Immunologic Factors; Lenalidomide; nef Gene Products, Human Immunodeficiency Virus; RNA, Messenger; Species Specificity; Thalidomide | 2012 |
Lenalidomide enhancement of human T cell functions in human immunodeficiency virus (HIV)-infected and HIV-negative CD4 T lymphocytopenic patients.
Topics: Adult; CD4-CD8 Ratio; Chemotaxis; HIV Infections; Humans; Interleukin-2; Lenalidomide; Male; Middle Aged; T-Lymphocytes; T-Lymphocytopenia, Idiopathic CD4-Positive; Thalidomide | 2012 |
Thalidomide and a thalidomide analogue drug costimulate virus-specific CD8+ T cells in vitro.
Topics: Adjuvants, Immunologic; CD8-Positive T-Lymphocytes; Cell Division; Coculture Techniques; Cytokines; Cytomegalovirus Infections; Dendritic Cells; Dose-Response Relationship, Immunologic; Flow Cytometry; HIV Infections; Humans; Immunosorbent Techniques; Lenalidomide; Thalidomide | 2003 |